Scotia Capital’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Scotia Capital’s Portfolio NMRD Stock Details NMRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,250	Closed	-$9K	–	783
2019 Q3	$9K	Hold	1,250	–	–	﹤0.01%	722
2019 Q2	$13K	Hold	1,250	–	–	﹤0.01%	719
2019 Q1	$13K	Hold	1,250	–	–	﹤0.01%	692
2018 Q4	$11K	Hold	1,250	–	–	﹤0.01%	651
2018 Q3	$30K	Hold	1,250	–	–	﹤0.01%	708
2018 Q2	$57K	Hold	1,250	–	–	﹤0.01%	652
2018 Q1	$57K	Buy	+1,250	New	+$66.3K	﹤0.01%	683

Other funds holding NMRD

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Scotia Capital's NMRD Position: Q4 2019 in Review

Scotia Capital sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q4 2019, closing a stake of 1,250 shares — an estimated $9K sold.

Scotia Capital first reported a position in NMRD in Q1 2018 and held it in 7 quarters. The position peaked at $57K in Q2 2018. 1 fund tracked by Wall St. Rank holds NMRD as of Q4 2019.

Scotia Capital reported no remaining Nemaura Medical, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Scotia Capital sold 1,250 Nemaura Medical, Inc. Common Stock shares in Q4 2019, an estimated $9K.
Scotia Capital first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Scotia Capital's Nemaura Medical, Inc. Common Stock position peaked at $57K in Q2 2018.
1 fund tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q4 2019.

Based on Scotia Capital's 13F filing for Q4 2019, filed 13 Feb 2020.